This second article in our series looking at some of the shortlisted candidates focuses on Novartis' meningococcal B vaccine Bexsero. Few infections will strike as much fear into a parent as ...

The second category of meningococcal vaccines protects against bacteria that fall into serogroup B. These are called MenB vaccines and are sold under the brand names Bexsero and Trumenba. The Food and ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended Novartis’ meningitis B vaccine, Bexsero, for approval for use in patients aged 2 months or older.

Scientific Conference by GlaxoSmithKline on the Launch of “Bexsero,” Egypt’s First Vaccine for the Prevention of Meningococcal Bacterial Meningitis (Group B) Sunday 13 Apr 2025 ...

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to ...

GSK’s 5-in-1 meningococcal vaccine PENMENVY receives positive recommendation from US Advisory Committee on Immunization Practices ...

The deal comes less than a month after GSK, the UK's largest drugmaker, completed the acquisition of the Bexsero vaccine against the potentially deadly disease from Novartis of Switzerland. The ...

Vaccine recommended to help protect persons over 10 years old in the United States ... Please consult the full Prescribing Information for additional safety information. Important Safety Information ...

GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) immunisation panel as part of the adolescent meningococcal vaccination ...

Vaccine recommended to help protect persons ... Important Safety Information for BEXSERO in the US The following is based on the US Prescribing Information for BEXSERO. Please consult the full ...